Home › Bristol-Myers completes diabetes business sale
 

Keywords :   


Bristol-Myers completes diabetes business sale

2014-02-03 17:46:40| Biotech - Topix.net

Drug developer Bristol-Myers Squibb Co. has received a $2.7 billion payment from Anglo-Swedish counterpart AstraZeneca PLC as part of the sale of its global diabetes business, a deal that could eventually be worth more than $4 billion.

Tags: business sale diabetes completes

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
More »